Investor FAQs

Where is Climb Bio’s corporate headquarters?

Climb Bio
20 Williams Street, Suite 145
Wellesley Hills, MA 02481

Where is the Company incorporated?

The Company is incorporated in Delaware.

What is Climb Bio’s fiscal year?

The Company’s fiscal year ends December 31st.

How is Climb Bio’s stock traded?

Our common stock is listed on the NASDAQ Global Market under the symbol “CLYM”.

Who is Climb Bio’s transfer agent?

The transfer agent and registrar for the common stock of Climb Bio's stock is
EQ
6201 15th Ave,
Brooklyn, NY 11219
(800) 937-5449

Whom do I contact with questions about my stock?

For questions about your stock please contact our transfer agent, EQ

How do I transfer stock, change the address on my shareholder account, or replace a lost stock certificate?

To change the address on your shareholder account you must send both your old and new addresses to our transfer agent, EQ, 6201 15th Ave, Brooklyn, NY 11219

To transfer stock or replace a lost stock certificate, contact our transfer agent, EQ

Who is the Company's auditor?

The auditor for Climb Bio is PricewaterhouseCoopers LLP located in Seattle, WA.

Who is the Company’s legal counsel?

Legal counsel for Climb Bio is Wilmer Cutler Pickering Hale and Dorr LLP located in New York, NY

Where can I find out more about Climb Bio?

To find out more about Climb Bio visit our webpage at climbbio.com.

Where can I get the latest corporate news releases and financial reports?

Climb Bio’s press release archive can be viewed under the “Press Releases” section under the “News & Events” of the “Investors & News” page and financial reports are available under the “Financials & Filings” section of the "Investors & News" page under the “Governance & Financials” page located at our website: climbbio.com.

How can I view documents Climb Bio has filed with the Securities & Exchange Commission (SEC), including Forms 10-K and 10-Q?

Climb Bio’s SEC Filings can be found on www.sec.gov and are also available under the “Financials & Filings” section under the “Governance & Financials” of the “Investors & News” page located at our website climbbio.com.

Whom should I contact regarding investor inquiries?

For investor inquiries please contact:

Brett Kaplan, M.D.
Climb Bio
Chief Operating Officer
EMAIL: InvestorRelations@climbbio.com

Christopher F. Brinzey
ICR Westwicke for Climb Bio
EMAIL: chris.brinzey@westwicke.com
PHONE: + 1 339-970-2843